ADVANCEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PROGRAMS

Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the sphere of biopharmaceuticals, providing promising enhancements across several medical and industrial applications. With its structural similarity to By natural means derived human serum albumin, OsrHSA supplies a safer, additional trustworthy alternative for the